Asset

LARONIDASE

BioMarin Pharmaceutical Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (1)

ApplicationTypeApplicant
BLA 125058BLABioMarin Pharmaceutical Inc.

Marketed products (1)

  • ALDURAZYME